Short description
The Evidence Behind the Hype.
A physician-reviewed, evidence-based examination of CJC-1295 from the Founder’s Institute of Medicine & Education.
This digital monograph separates demonstrated human pharmacodynamic effects from broader claims about body composition, recovery, performance, anti-aging, and longevity that remain incompletely established.
Full product description
CJC-1295 produces measurable biological effects in humans. But what do those effects actually mean clinically?
CJC-1295 is a growth hormone-releasing hormone analog commonly discussed for increasing growth hormone and IGF-1, improving body composition, accelerating recovery, enhancing performance, and promoting healthy aging.
Unlike many peptides promoted in the wellness market, CJC-1295 has published human research demonstrating measurable effects on the GH/IGF-1 axis.
That makes the evidence particularly interesting—but it also makes careful interpretation essential.
Demonstrating a hormonal response is not the same as demonstrating a meaningful clinical benefit.
Rather than extending pharmacodynamic findings into claims the studies were not designed to prove, this monograph separates established human observations from hypotheses, extrapolations, and unanswered questions.
Using the Founder’s Institute Peptide Evidence Standard (FIPES), claims are evaluated individually and the strength, maturity, safety knowledge, and human relevance of the supporting evidence are made transparent.
Inside the monograph
- What CJC-1295 is and how it interacts with the GH/IGF-1 axis
- Human pharmacokinetic and pharmacodynamic evidence
- What increases in GH and IGF-1 do—and do not—establish
- Body-composition and recovery claims
- Performance and anti-aging claims
- Safety signals and unresolved long-term risks
- Product identity, formulation, and quality considerations
- FDA and regulatory context
- Claim-by-claim FIPES evidence grading
- What we know, what we do not know, and what research is still needed
Physician reviewed. Evidence graded. No protocols. No dosing instructions. No promotional claims.
This publication is intended for education and scientific evidence review. It is not medical advice and does not recommend or instruct the use of CJC-1295.